CNBC US Markets12.05.2026PolitiqueUnited States
FDA Commissioner Dr. Marty Makary Resigns Amid Controversy
Makary's tenure marked by internal dysfunction and regulatory backlash
L'essentiel
Dr. Marty Makary resigned as FDA commissioner amid controversy and internal dysfunction, to be replaced by Kyle Diamantas as acting commissioner
Résumé généré par IA
Taille de police
Dr. Marty Makary resigned as FDA commissioner amid controversy and internal dysfunction, to be replaced by Kyle Diamantas as acting commissioner
Sujets liés
This article was originally published by CNBC US Markets.
